-- Products: JAMP-Clopidogrel 75 mg and AG-Clopidogrel 75 mg tablets -- Issue: Health products -- Product safety -- What to do: If you are taking the affected products, speak with your pharmacist as ...
DALLAS, TX — Long-term ischemic and bleeding risks climb with advancing age in elderly patients medically managed for acute coronary syndromes (ACS), as might be expected, but adding low-dose ...
CURE was one of four large clinical trials that provide a body of evidence that supports the use of dual antiplatelet therapy in patients with acute coronary syndromes and in those undergoing ...
Researchers at 37 sites in South Korea have found patients taking clopidogrel after percutaneous coronary intervention (PCI) experienced lower rates of both thrombotic and bleeding events than those ...
Among secondary-prevention patients who are event free for 6 to 18 months after PCI, clopidogrel seems to be superior to aspirin monotherapy over the next 2 years regardless of the patient’s baseline ...
Munich, Germany – The first trial to study the effect of platelet inhibition in patients with acute coronary syndromes managed medically without revascularisation has found no significant difference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results